|[October 15, 2013]
Research and Markets: Global Dengue Clinical Trials Review, H2 2013
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/hzhhkh/dengue_global)
has announced the addition of the "Dengue
Global Clinical Trials Review, H2, 2013" report to their
"Dengue Global Clinical Trials Review, H2, 2013" provides data on the
Dengue clinical trial scenario. This report provides elemental
information and data relating to the clinical trials on Dengue. It
includes an overview of the trial numbers and their recruitment status
as per the site of trial conduction across the globe. The databook
offers a preliminary coverage of disease clinical trials by their phase,
trial status, prminence of the sponsors and also provides briefing
pertaining to the number of trials for the key drugs for treating Dengue.
Reasons to buy
Understand the dynamics of a particular indication in a condensed
Abridged view of the performance of the trials in terms of their
status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes /
Hospitals or Companies
Top Companies Participating in Dengue Therapeutics Clinical Trials
Sanofi Pasteur SA
Themis Bioscience GmbH
F. Hoffmann-La Roche Ltd.
Hawaii Biotech, Inc.
Innogene Kalbiotech Pte. Ltd.
Novo Nordisk A/S
Merck & Co., Inc.
For more information visit http://www.researchandmarkets.com/research/hzhhkh/dengue_global.
About Research and Markets
Research and Markets is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.
[ Back To Technology News's Homepage ]